Comparable stake leader
FMR LLC
SEC ownership of Legend Biotech Corp
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001801198.
Disclosed value leader
FMR LLC
Comparable rows
50/50
Latest evidence
24 Jul 2026
- Public ticker
- LEGN on Nasdaq
- Parsed ownership sources
-
13D/G, 13F, and 3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
FMR LLC
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
50 of 50
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
FMR LLC
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
24 Jul 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001801198
- Issuer location
- Somerset, NJ
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Legend Biotech Corp (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
50/50
Latest evidence
24 Jul 2026
13D/G
13F
3/4/5
Lead comparable stake: 13%
13D/G row: FMR LLC
Showing 1-8 of 50 holder rows.
Quick read
FMR LLC leads the comparable SEC ownership view at 13%.
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens FMR LLC's linked filing trail.
Comparable ownership
Top 5
FMR LLC
13%
PRICE T ROWE ASSOCIATES INC /MD/
3.7%
Ying Huang
0.06%
Darren Xiaohui Ji
0.02%
Corazon (corsee) D. Sanders
0.02%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13D/G
13F
Company
|
13%
|
$1,049,921,245
48,294,445 shares
|
-$147,815,434 | 31 Dec 2025 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13D/G
T. Rowe Price Associates, Inc.
|
3.7%
|
$233,379,028
6,808,023 shares
|
$0 | 31 Dec 2024 |
| Ying Huang |
3/4/5
Chief Executive Officer, Director
|
0.06%
|
$4,314,284
238,490 shares
|
-$169,404 | 30 Jun 2026 |
| Darren Xiaohui Ji |
3/4/5
Director
|
0.02%
|
$1,259,516
63,773 shares
|
— | 18 Mar 2026 |
| Corazon (corsee) D. Sanders |
3/4/5
Director
|
0.02%
|
$1,167,521
59,115 shares
|
— | 18 Mar 2026 |
| Patrick John Casey |
3/4/5
Director
|
0.01%
|
$719,339
48,604 shares
|
-$88,800 | 30 Jun 2026 |
| Li Mao |
3/4/5
Director
|
0.01%
|
$875,517
44,330 shares
|
— | 18 Mar 2026 |
| Tomas J. Heyman |
3/4/5
Director
|
0.01%
|
$646,496
32,734 shares
|
— | 18 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to selling over the last 12 months. Net value: -$258,204.
Buys
$0
Insiders: 0
Sells
$258,204
Insiders: 2
Net
-$258,204
Shares: -21,502
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 21,502
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 11,566 | $0 | $171,065 | -$171,065 |
| 3-6 | 0 | 9,936 | $0 | $87,139 | -$87,139 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-13 of 13 reporting-owner rows connected to Legend Biotech Corp. Open a relationship link for the CIK-to-CIK filing trail.
Rows
13
Largest Forms 3/4/5 holder
Ying Huang
Net 12M change
-$258,204
Latest report
24 Jul 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Ying Huang | Chief Executive Officer, Director | $4,314,284 | -$169,404 | -3.8% | Mixed | 30 Jun 2026 |
| Darren Xiaohui Ji | Director | $1,259,516 | Mixed | 18 Mar 2026 | ||
| Corazon (corsee) D. Sanders | Director | $1,167,521 | Mixed | 18 Mar 2026 | ||
| Li Mao | Director | $875,517 | Mixed | 18 Mar 2026 | ||
| Alan Bash | Interim CEO | $873,157 | Median | 24 Jul 2026 | ||
| Patrick John Casey | Director | $719,339 | -$88,800 | -11% | Filing P/S | 30 Jun 2026 |
| Tomas J. Heyman | Director | $646,496 | Mixed | 18 Mar 2026 | ||
| Gareth Kung | Director | $621,848 | Mixed | 18 Mar 2026 | ||
| Peter Salovey | Director | $528,628 | Mixed | 18 Mar 2026 | ||
| Ye Wang | Director | $316 | Mixed | 18 Mar 2026 | ||
| Robin Meng | Director | Mixed | 18 Mar 2026 | |||
| Fangliang Zhang | Director | Mixed | 18 Mar 2026 | |||
| Carlos E. Santos | Chief Financial Officer | Mixed | 18 Mar 2026 |
Recent insider transactions for Legend Biotech Corp
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Patrick John Casey | LEGN | Ordinary Shares | Sale | -11% | $88,800 | $14.80 | -6,000 | 48,604 | 30 Jun 2026 | Direct |
| Ying Huang | LEGN | Ordinary Shares | Gift | -1.4% | -3,382 | 238,490 | 30 Jun 2026 | Direct | ||
| Ying Huang | LEGN | Ordinary Shares | Sale | -2.25% | $82,265 | $14.78 | -5,566 | 241,872 | 25 Jun 2026 | Direct |
| Ying Huang | LEGN | Ordinary Shares | Sale | -3.86% | $87,139 | $8.77 | -9,936 | 247,438 | 25 Mar 2026 | Direct |
* marks a reported price that did not pass the local price check.